Delivery Order SPM2D013D0005-SPE2D018F0140
Award Date
5/16/18
Potential Completion Date
6/24/19
Potential Value
$398K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded an $690,616 delivery order to Genentech USA, Inc. of South San Francisco, California under contract number 8507376885 for other medical products and services. The firm fixed price order has a period of performance from May 15, 2020 to June 30, 2021 for products and services to be delivered to South San Francisco. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports Department of Defense health...
The Defense Logistics Agency Troop Support Medical awarded a $116,303.04 delivery order contract to Genentech USA, Inc. for the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals that has held numerous indefinite delivery contracts and blanket purchase agreements with various federal agencies for critical biologic medicines. This contract does not utilize any set-asides and will be performed at Genentech's facility in South San...
This federal contract award, SPE2DP16D0008|0051, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $76,496.94 firm-fixed-price delivery order is for the supply of oseltamivir phosphate, an antiviral medication, with a period of performance through September 11, 2018. Genentech holds several major contract vehicles with federal agencies like the Department of Veterans Affairs and the Department...
This is a delivery order (SPE2DP16D0008|0041) awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $9,862,682.40 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication, to support the federal government's medical supply needs. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $10,739.70 firm fixed-price contract is for the supply of 4568495914 - TNKASE 50 MG KITS, with a completion date of June 12, 2025. The contract is not associated with a set-aside designation. Genentech has established several significant federal contract vehicles, including a $4.9 billion Federal Supply Schedule...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate (Tamiflu), an antiviral medication. The $141,052.05 firm-fixed-price delivery order is not associated with any set-aside designation. Genentech holds several established contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of oseltamivir phosphate, an antiviral medication, with a ceiling value of $85,938.87. The contract has a firm fixed price and does not utilize any set-aside designations. Genentech has several existing contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company. The $93,573.18 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication. The award falls under a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to supply medical supplies and critical pharmaceuticals for the Department of Defense. No set-aside designation was used....
This is a $1,416,911.91 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of a variety of pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,543.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The contract provides for the delivery of XGEVA 120 MG/1.7 ML VIAL 1.7ML, a specialty pharmaceutical...